Chembio Diagnostics Gets CLIA Waiver for HIV-Syphilis Dual Rapid Test
The test can detect both HIV and syphilis from a single sample in 15 minutes using fingerstick blood, venous whole blood, or plasma.
Simple HealthKit Raises $8M in Series A Round
The California startup sells PCR-based tests for respiratory and sexually transmitted diseases and said it will use the funding toward innovation and expanded sales of its products.
Biosynex to Acquire Chembio Diagnostics for $17.2M
Biosynex will buy all of Chembio's shares at $.45 per share in an all-cash deal that merges two developers and makers of point-of-care diagnostic tests.
Among potential growth opportunities, the firm's new CEO noted hospital lab M&A and STD and cancer testing.
COVID-19 Still a Focus for Infectious Disease Test Developers in 2022, but Ceded Some Ground
Tests for other respiratory viruses, as well as sexually transmitted infections and tuberculosis, moved back into the development pipeline last year.